She held various roles across academia and the pharmaceutical/biotech sector (Millennium Pharmaceuticals, Novartis, Merck KGaA). Most recently, she supported the Translational Sciences leadership team for monitoring pharmacology, toxicology and clinical biomarker development functions at Sarepta Therapeutics and provided project management support to the Sarepta Program Office in advancing the Duchenne Muscular Dystrophy RNA-targeted therapeutic programs, from early development to marketed stages.
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science